UNUSUAL MACHINES INC /US (UMAC)

US91532F1021 - Common Stock

18.73  +8.84 (+89.38%)

After market: 18.1701 -0.56 (-2.99%)

Fundamental Rating

2

UMAC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 125 industry peers in the Electronic Equipment, Instruments & Components industry. While UMAC seems to be doing ok healthwise, there are quite some concerns on its profitability. UMAC has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year UMAC has reported negative net income.
UMAC had a negative operating cash flow in the past year.

1.2 Ratios

The Return On Assets of UMAC (-13.84%) is worse than 70.16% of its industry peers.
With a Return On Equity value of -17.47%, UMAC is not doing good in the industry: 65.32% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -13.84%
ROE -17.47%
ROIC N/A
ROA(3y)-52.93%
ROA(5y)N/A
ROE(3y)-56.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 29.19%, UMAC perfoms like the industry average, outperforming 46.77% of the companies in the same industry.
UMAC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

UMAC has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

UMAC has an Altman-Z score of 8.88. This indicates that UMAC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.88, UMAC belongs to the top of the industry, outperforming 87.90% of the companies in the same industry.
UMAC has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
UMAC has a Debt to Equity ratio of 0.20. This is comparable to the rest of the industry: UMAC outperforms 45.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 8.88
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

UMAC has a Current Ratio of 5.50. This indicates that UMAC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.50, UMAC belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
UMAC has a Quick Ratio of 3.74. This indicates that UMAC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.74, UMAC belongs to the best of the industry, outperforming 81.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.5
Quick Ratio 3.74

1

3. Growth

3.1 Past

UMAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -105.09%.
EPS 1Y (TTM)-105.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-221.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, UMAC will show a very strong growth in Earnings Per Share. The EPS will grow by 32.37% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.92%
EPS Next 2Y32.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UMAC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UMAC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as UMAC's earnings are expected to grow with 32.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

UMAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UNUSUAL MACHINES INC /US

NYSEARCA:UMAC (11/29/2024, 2:15:04 PM)

After market: 18.1701 -0.56 (-2.99%)

18.73

+8.84 (+89.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap155.46M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.84%
ROE -17.47%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 29.19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.5
Quick Ratio 3.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-105.09%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-18.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y